Indo Borax & Chemicals Limited has informed the Exchange that Board of Directors at its meeting held on May 13, 2025, recommended Final Dividend of 1 per equity share.
INDOBORAX · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 5.0 pts less than Nifty Microcap 250 and 3.4 pts less than its Commodity Chemicals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
The Board of Directors of Indo Borax & Chemicals, at its meeting held on May 13, 2025, approved the audited standalone and consolidated financial results for Q4 and FY ended March 31, 2025, and recommended a final dividend of Rs. 1 per equity share (100% on face value of Rs. 1), subject to shareholder approval. For FY25, standalone revenue from operations fell to Rs. 17,526.11 lakhs from Rs. 19,130.30 lakhs in FY24, but net profit rose to Rs. 4,188.20 lakhs (from Rs. 3,841.24 lakhs) and EPS improved to Rs. 13.05 from Rs. 11.97. Q4 FY25 standalone net profit stood at Rs. 1,007.44 lakhs versus Rs. 1,129.33 lakhs in the year-ago quarter. The statutory auditor issued an unmodified opinion, but flagged an emphasis of matter regarding an inter-corporate deposit given to a third party that is under IBC insolvency proceedings, with the company awaiting the NCLT outcome.
Shareholders will receive Rs. 1 per share dividend pending AGM approval. While profit growth and a clean audit opinion are positives, the decline in full-year revenue and the negative operating cash flow of Rs. (6,093.68) lakhs (compared to a positive Rs. 6,971.01 lakhs last year) are points of concern, alongside the unresolved NCLT-linked ICD exposure flagged by the auditor.